Lexeo Therapeutics, Inc. (LXEO) stock
LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.85−0.38 (-11.61%)
Close on Nov 17, 2026Market cap $234.24MP/E –Yield –
Lexeo Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lexeo Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 4.5× a year earlier. Over the last 3 years it ranged from 0.8× to 4.5×, with a median of 1.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −3.5 |
| 2025 | Dec 31, 2025 | 4.5× | +3.0 |
| 2024 | Dec 31, 2024 | 1.6× | – |
See a number that looks wrong?